Center for Scientific Review; Notice of Closed Meeting, 70956 [2013-28375]
Download as PDF
<![CDATA[
70956
Federal Register / Vol. 78, No. 229 / Wednesday, November 27, 2013 / Notices
variety of normal tissues, including
hematopoietic stem cells, neurons, and
dendritic cells. The other domain is
BclxL, which prevents targeted cell
death. GMCSF-BclxL chimeric protein
could potentially be used as an adjuvant
to treat cancer and to treat acute
neurological disorders (such as brain or
spinal cord injury, stroke) or chronic
CNS diseases (Alzheimers, Parkinson’s,
and ALS). It could be used to prevent
hematopoietic cell loss during chemo or
radiotherapy. It could also be used in
patients receiving stem cell
transplantation or in ex vivo expansion
of hematopoietic stem and progenitor
cells.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless
within thirty (30) days from the date of
this published notice, the NIH receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: November 21, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development
& Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2013–28374 Filed 11–26–13; 8:45 am]
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: December 6, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Shiv A Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 21, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–28375 Filed 11–26–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
New Mexico; Amendment No. 1 to
Notice of a Major Disaster Declaration
SUMMARY:
emcdonald on DSK67QTVN1PROD with NOTICES
18:02 Nov 26, 2013
Jkt 232001
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5683–N–103]
30-Day Notice of Proposed Information
Collection: Assessment of Native
American, Alaska Native and Native
Hawaiian Housing Needs
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
BILLING CODE 9111–23–P
[Internal Agency Docket No. FEMA–4148–
DR; Docket ID FEMA–2013–0001]
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
[FR Doc. 2013–28473 Filed 11–26–13; 8:45 am]
AGENCY:
AGENCY:
Center for Scientific Review; Notice of
Closed Meeting
W. Craig Fugate,
Administrator, Federal Emergency
Management Agency.
Federal Emergency Management
Agency
BILLING CODE 4140–01–P
National Institutes of Health
Sierra County and the Navajo Nation for
Public Assistance.
The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034,
Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant;
97.048, Disaster Housing Assistance to
Individuals and Households In Presidentially
Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance—
Disaster Housing Operations for Individuals
and Households; 97.050 Presidentially
Declared Disaster Assistance to Individuals
and Households—Other Needs; 97.036,
Disaster Grants—Public Assistance
(Presidentially Declared Disasters); 97.039,
Hazard Mitigation Grant.
This notice amends the notice
of a major disaster declaration for the
State of New Mexico (FEMA–4148–DR),
dated September 30, 2013, and related
determinations.
DATES: Effective Date: November 20,
2013.
FOR FURTHER INFORMATION CONTACT:
Dean Webster, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street SW.,
Washington, DC 20472, (202) 646–2833.
SUPPLEMENTARY INFORMATION: The notice
of a major disaster declaration for the
State of New Mexico is hereby amended
to include the following areas among
those areas determined to have been
adversely affected by the event declared
a major disaster by the President in his
declaration of September 30, 2013.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Office of the Chief Information
Officer, HUD.
Notice.
HUD has submitted the
proposed information collection
requirement described below to the
Office of Management and Budget
(OMB) for review, in accordance with
the Paperwork Reduction Act. The
purpose of this notice is to allow for an
additional 30 days of public comment.
SUMMARY:
Comments Due Date: December
27, 2013.
DATES:
Interested persons are
invited to submit comments regarding
this proposal. Comments should refer to
the proposal by name and/or OMB
Control Number and should be sent to:
HUD Desk Officer, Office of
Management and Budget, New
Executive Office Building, Washington,
DC 20503; fax: 202–395–5806. Email:
OIRA_Submission@omb.eop.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Colette Pollard, Reports Management
Officer, QDAM, Department of Housing
and Urban Development, 451 7th Street
SW., Washington, DC 20410; email
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 78, Number 229 (Wednesday, November 27, 2013)]
[Notices]
[Page 70956]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28375]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: AIDS and AIDS Related Research.
Date: December 6, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Shiv A Prasad, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892, 301-443-
5779, prasads@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 21, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-28375 Filed 11-26-13; 8:45 am]
BILLING CODE 4140-01-P
